Larson Financial Group’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.46K Sell
1,536
-3,324
-68% -$27.6K ﹤0.01% 2283
2025
Q4
$50.6K Buy
4,860
+881
+22% +$8.84K ﹤0.01% 1221
2025
Q3
$35.8K Buy
3,979
+2,089
+111% +$18.3K ﹤0.01% 1313
2025
Q2
$24.6K Buy
1,890
+149
+9% +$2.24K ﹤0.01% 1380
2025
Q1
$44K Buy
1,741
+205
+13% +$6.09K ﹤0.01% 1076
2024
Q4
$52.8K Hold
1,536
﹤0.01% 883
2024
Q3
$75.9K Buy
1,536
+550
+56% +$28.2K ﹤0.01% 791
2024
Q2
$59.3K Hold
986
﹤0.01% 770
2024
Q1
$50.9K Buy
+986
New +$48.4K ﹤0.01% 685

Other funds holding RXST

Larson Financial Group's RXST Position: Q1 2026 in Review

Larson Financial Group reduced its RxSight (RXST) stake by 68% in Q1 2026, selling an estimated $27.6K and leaving 1,536 shares worth $9.46K. The position accounts for ﹤0.01% of the portfolio, ranked #2283.

Larson Financial Group first reported a position in RXST in Q1 2024 and has held it in 9 quarters since. The position peaked at $75.9K in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Larson Financial Group held 1,536 shares of RxSight worth $9.46K as of Q1 2026.
  • Larson Financial Group sold 3,324 RxSight shares in Q1 2026, an estimated $27.6K.
  • RxSight made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2283 holding.
  • Larson Financial Group first reported a position in RxSight in Q1 2024 and has held it in 9 quarters since.
  • Larson Financial Group's RxSight position peaked at $75.9K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.